Melatonin; An established radioprotective agent against Japan’s nuclear disaster

Yaygın kullanımına ve iyonizan radyasyona maruziyetin iyi bilinen potansiyel tehlikelerine rağmen ülkeler, Japonya’nın kuzeydoğusunda görüldüğü gibi nükleer patlamaya bağlı salınım durumunda kendi vatandaşlarını korumak için çaresiz bir şekilde kötü donanıma sahiptirler. Nükleer patlamaya bağlı salınım durumunda insanları iyonizan radyasyonun tehlikeli etkilerinden koruyacak pratik bir yol yoktur. Sağlık otoriteleri tiroid kanserlerini önlemek için insanlara potasyum iyodür dağıtabilirler. Bir diğer koruyucu girişim radyoprotektif özellikleri ile tanınan amifostin kullanımı olabilir. Melatonin (N-asetil-5-metoksi triptamin) pineal bezden salınan, güçlü radyoprotektif özellikleri bilinen bir üründür. Melatoninin benzersiz bir antioksidan olduğu ve iyonizan radyasyonu da içeren bir çok tehlikeli ajana karşı DNA ve kromozom koruyucusu olduğu hem insan hem hayvan deneylerinde açıkça gösterilmiştir.

Melatonin; Japon nükleer felaketine karşı etkin bir radyasyondan koruyucu ajan

In spite of its widespread use and the well known potential hazards associated with exposure to ionizing radiation, countries are poorly ill-equipped to protect their citizens in case of a fallout as seen in northeastern region of Japan. In case of nuclear fallout, there is no practical way to save people from the hazardous effects of ionizing radiation. Health authorities may provide potassium iodide for people to prevent thyroid cancer. Another preventive attempt would be using amifostine, a well known agent with radioprotective features. Melatonin (N-acetyl-5-methoxytryptamine) is a pineal product which is also known to have robust radioprotective features. Both human and experimental animal studies have clearly shown that it is a unique antioxidant and a DNA and chromosome protector against a variety of harmful agents including ionizing radiation

___

  • 1 Preston RJ. Radiation biology: concepts for radiation protection. Health Phys. 2004; 87(1): 3-14.
  • 2 Sadetzki S. Childhood exposure to external ionising radiation and solid cancer risk. British journal of cancer. 2009; 100(7): 1021-1025.
  • 3 Langell J. Pharmacological agents for the prevention and treatment of toxic radiation exposure in spaceflight. Aviation, space, and environmental medicine. 2008; 79(7): 651-660.
  • 4 Kouvaris JR. Amifostine: the first selective-target and broad-spectrum radioprotector. The oncologist. 2007; 12(6): 738-747.
  • 5 Grdina DJ. Amifostine: mechanisms of action underlying cytoprotection and chemoprevention. Drug metabolism and drug interactions. 2000; 16(4): 237-279.
  • 6 Vijayalaxmi. Melatonin and radioprotection from genetic damage: in vivo/in vitro studies with human volunteers. Mutation research. 1996; 371(3-4): 221-228.
  • 7 Vijayalaxmi. Melatonin reduces gamma radiation-induced primary DNA damage in human blood lymphocytes. Mutation research. 1998; 397(2): 203-208.
  • 8 Vijayalaxmi. Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutation research. 1995; 346(1): 23-31.
  • 9 Vijayalaxmi. Melatonin and protection from whole-body irradiation: survival studies in mice. Mutation research. 1999; 425(1): 21-27.
  • 10 Vijayalaxmi. Melatonin and protection from genetic damage in blood and bone marrow: whole-body irradiation studies in mice. Journal of pineal research. 1999; 27(4): 221-225.
  • 11 Take G. Effect of melatonin and time of administration on irradiation-induced damage to rat testes. Brazilian journal of medical and biological research=Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica [et al]. 2009; 42(7): 621-628.
  • 12 Karbownik M. Protective effects of melatonin against oxidation of guanine bases in DNA and decreased microsomal membrane fluidity in rat liver induced by whole body ionizing radiation. Molecular and cellular biochemistry. 2000; 211(1-2): 137-144.
  • 13 Assayed ME. Protection of rat chromosomes by melatonin against gamma radiation-induced damage. Mutation research. 2009; 677(1-2): 14-20.
  • 14 Vijayalaxmi. Melatonin as a radioprotective agent: a review. International journal of radiation oncology, biology, physics. 2004; 59(3): 639-653.
  • 15 Topkan E. Comparison of the protective effects of melatonin and amifostine on radiation-induced epiphyseal injury. International journal of radiation biology. 2008; 84(10): 796-802.
  • 16 Onal C. Protective effects of melatonin and octreotide against radiation-induced intestinal injury. Digestive diseases and sciences. 2011; 56(2): 359-367.
  • 17 Hardeland R. Melatonin and its metabolites as anti-nitrosating and anti-nitrating agents. J Exp and Integr Med. 2011; 1(2): 67-81.
  • 18 Shirazi A. A radiobiological review on melatonin: a novel radioprotector. Journal of radiation research. 2007; 48(4): 263-272.
  • 19 Longatti P, Perin A, Rizzo V, Comai S, Giusti P, Costa CV. Ventricular cerebrospinal fluid melatonin concentrations investigated with an endoscopic technique. J Pineal Res. 2007; 42(2): 113-118.
  • 20 Koppisetti S, Jenigiri B, Terron MP, Tengattini S, Tamura H, Flores LJ, et al. Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review. Dig Dis Sci. 2008; 53(10): 2592-2603.
  • 21 Tamura H, Nakamura Y, Korkmaz A, et all. Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril. 2009; 92(1): 328-343.
  • 22 Seabra ML, Bignotto M, Pinto LR, Jr., Tufik S. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res. 2000; 29(4): 193-200.
  • 23 Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci. 1999; 50(2): 271-279.
  • 24 Reiter RJ, Gultekin F, Flores LJ, Terron MP, Tan DX. Melatonin: potential utility for improving public health. TAF Prev Med Bull. 2006; 5(2): 131-158.
  • 25 Das B, Bennett PV, Cutter NC, Sutherland JC, Sutherland BM. Melatonin protects human cells from clustered DNA damages, killing and acquisition of soft agar growth induced by X-rays or 970 MeV/n Fe ions. International journal of radiation biology. Int J Radiat Biol. 2011. [Epub ahead of print].